Company profile

Symetis

Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurate™Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.

Source: startup.ch

More news about Symetis

03.04.2017 08:10

Symetis to be bought by Boston Scientific for $435 million

Financing

20.03.2017 09:10

Symetis launches its IPO on Euronext Paris

Financing

14.02.2017 10:39

Symetis Acquires U.S. Medtech Company

Expansion

01.09.2015 16:03

Symetis announces IPO on SIX Swiss Exchange

Financing

17.04.2015 11:52

Nine hot start-ups, 400 visitors and Joe Jimenez

Support

22.09.2014 08:38

Symetis launches second product

Launch

31.10.2013 09:08

1000th Patient implanted with Symetis‘ ACURATE TA

19.04.2013 14:17

Symetis bioprosthesis confirms superior results

23.10.2012 15:03

Trial of second Symetis product successfully completed

07.10.2011 14:24

Symetis Aortic Bioprosthesis Receives CE Mark

Founded
2001

Kanton
VD

Homepage

Principal

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.